76 related articles for article (PubMed ID: 2166933)
1. Flow cytometry measurement of nuclear RNA content in uveal melanoma.
Chen TC; Char DH; Waldman F; Juster RP
Ophthalmic Res; 1990; 22(3):187-93. PubMed ID: 2166933
[TBL] [Abstract][Full Text] [Related]
2. Estimation of DNA content in uveal melanomas by flow cytometry.
Rennie IG; Rees RC; Parsons MA; Lawry J; Cottam D
Eye (Lond); 1989; 3 ( Pt 5)():611-7. PubMed ID: 2630338
[TBL] [Abstract][Full Text] [Related]
3. DNA content analysis of uveal melanoma.
McMillan J; Char DH; McLean IW; Gamel JW
Arch Ophthalmol; 1989 Sep; 107(9):1278. PubMed ID: 2783056
[No Abstract] [Full Text] [Related]
4. DNA index and S phase fraction in uveal malignant melanomas.
Hodge WG; Duclos AJ; Rocha G; Antecka E; Baines MG; Corriveau C; Brownstein S; Deschenes J
Br J Ophthalmol; 1995 Jun; 79(6):521-6. PubMed ID: 7626566
[TBL] [Abstract][Full Text] [Related]
5. DNA content abnormalities and prognosis in uveal melanoma.
Meecham WJ; Char DH
Arch Ophthalmol; 1986 Nov; 104(11):1626-9. PubMed ID: 3778276
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of DNA ploidy as assessed with flow cytometry in uveal melanoma.
Elavathil LJ; LeRiche J; Rootman J; Gallagher RP; Phillips D
Can J Ophthalmol; 1995 Dec; 30(7):360-5. PubMed ID: 8963937
[TBL] [Abstract][Full Text] [Related]
7. DNA index and % S phase fraction in posterior uveal melanoma: a 5 year prospective study of fresh tissue using flow cytometry.
Richardson RP; Lawry L; Rees RC; Rennie IG
Eye (Lond); 1997; 11 ( Pt 5)():629-34. PubMed ID: 9474308
[TBL] [Abstract][Full Text] [Related]
8. DNA flow cytometry in uveal melanoma: the effect of pre-enucleation irradiation.
Mooy C; Vissers K; Luyten G; Mulder A; Stijnen T; de Jong P; Bosman F
Br J Ophthalmol; 1995 Feb; 79(2):174-7. PubMed ID: 7696240
[TBL] [Abstract][Full Text] [Related]
9. [Cellular type of uveal melanoblastomas of the eye and the nuclear DNA content (a cytophotometric study)].
Vit VV
Oftalmol Zh; 1982; 37(8):502-7. PubMed ID: 7162748
[No Abstract] [Full Text] [Related]
10. Uveal melanoma trapped in the temple of doom.
Shields CL; Ganguly A; O'Brien J; Sato T; Shields JA
Am J Ophthalmol; 2012 Aug; 154(2):219-21. PubMed ID: 22813447
[No Abstract] [Full Text] [Related]
11. Carcinoembryonic antigen cell adhesion molecule-1 (CEACAM1) in posterior uveal melanoma: correlation with clinical and histological survival markers.
Khatib N; Pe'er J; Ortenberg R; Schachter J; Frenkel S; Markel G; Amer R
Invest Ophthalmol Vis Sci; 2011 Dec; 52(13):9368-72. PubMed ID: 22039239
[TBL] [Abstract][Full Text] [Related]
12. Epidemiological trends in uveal melanoma.
Andreoli MT; Mieler WF; Leiderman YI
Br J Ophthalmol; 2015 Nov; 99(11):1550-3. PubMed ID: 25904122
[TBL] [Abstract][Full Text] [Related]
13. MMP-9 is predominantly expressed in epithelioid and not spindle cell uveal melanoma.
El-Shabrawi Y; Ardjomand N; Radner H; Ardjomand N
J Pathol; 2001 Jun; 194(2):201-6. PubMed ID: 11400149
[TBL] [Abstract][Full Text] [Related]
14. Effect of heterogeneous distribution of monosomy 3 on prognosis in uveal melanoma.
Bronkhorst IH; Maat W; Jordanova ES; Kroes WG; Schalij-Delfos NE; Luyten GP; Jager MJ
Arch Pathol Lab Med; 2011 Aug; 135(8):1042-7. PubMed ID: 21809997
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic reprogramming and aberrant expression of PRAME are associated with increased metastatic risk in Class 1 and Class 2 uveal melanomas.
Field MG; Durante MA; Decatur CL; Tarlan B; Oelschlager KM; Stone JF; Kuznetsov J; Bowcock AM; Kurtenbach S; Harbour JW
Oncotarget; 2016 Sep; 7(37):59209-59219. PubMed ID: 27486988
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity of 1p in uveal melanomas with monosomy 3.
Häusler T; Stang A; Anastassiou G; Jöckel KH; Mrzyk S; Horsthemke B; Lohmann DR; Zeschnigk M
Int J Cancer; 2005 Oct; 116(6):909-13. PubMed ID: 15849744
[TBL] [Abstract][Full Text] [Related]
17. Sex Disparity in Survival of Patients With Uveal Melanoma: Better Survival Rates in Women Than in Men in South Korea.
Park SJ; Oh CM; Yeon B; Cho H; Park KH
Invest Ophthalmol Vis Sci; 2017 Mar; 58(3):1909-1915. PubMed ID: 28362882
[TBL] [Abstract][Full Text] [Related]
18. Clinical and cytogenetic analyses in uveal melanoma.
Kilic E; van Gils W; Lodder E; Beverloo HB; van Til ME; Mooy CM; Paridaens D; de Klein A; Luyten GP
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3703-7. PubMed ID: 16936076
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA expression analysis and Multiplex ligation-dependent probe amplification in metastatic and non-metastatic uveal melanoma.
Larsen AC; Holst L; Kaczkowski B; Andersen MT; Manfé V; Siersma VD; Kolko M; Kiilgaard JF; Winther O; Prause JU; Gniadecki R; Heegaard S
Acta Ophthalmol; 2014 Sep; 92(6):541-9. PubMed ID: 24373459
[TBL] [Abstract][Full Text] [Related]
20. Uveal melanoma prognostication: from lesion size and cell type to molecular class.
Gill HS; Char DH
Can J Ophthalmol; 2012 Jun; 47(3):246-53. PubMed ID: 22687301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]